Nowadays, in cancer treatments, immunotherapy which can be classified as a cancer type
specific therapy is more popular than non-specific therapy methods such as surgery …

Simple Summary Hematological malignancies are diseases involving the abnormal
production of blood cells. The aim of the study is to collect comprehensive information on …

Chimeric antigen receptor (CAR)-T cell therapy has shown remarkable clinical efficacy
against B-cell malignancies, yet marked vulnerability to antigen escape and tumor relapse …

The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Even though more than 30 years have passed since the eradication of smallpox, high titers
of smallpox-specific antibodies are still detected in the blood of subjects vaccinated in …

Antibodies have proven their high value in antitumor therapy over the last two decades.
They are currently being used as the first-choice to treat some of the most frequent …

Transformed plasma cells in multiple myeloma (MM) are susceptible to natural killer (NK)
cell-mediated killing via engagement of tumor ligands for NK activating receptors or “missing …

Multiple myeloma (MM) is a hematologic malignancy that is considered mostly incurable in
large part due to the inability of standard of care therapies to overcome refractory disease …

Multiple myeloma (MM) is an incurable hematologic malignancy. Most MM patients are
diagnosed at a late stage because the early symptoms of the disease can be uncertain and …

Outcomes in multiple myeloma (MM) have improved dramatically in the last two decades
with the advent of novel therapies including immunomodulatory agents (IMiDs), proteasome …